SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP is trending as investors debate whether the token is a long-term utility play or a failing project amid ongoing price stagnation and leadership transitions. While some community members remain committed to accumulating through the dip, others are expressing significant frustration over lack of communication and constant downward pressure on the token's value.

Fartcoin is a meme-driven cryptocurrency where users can submit their best fart jokes or memes to earn initial tokens. Each transaction triggers a hilarious 'Gas Fee' effect, complete with a digital fart sound for maximum comedic impact.

Fartcoin

Fartcoin is drawing intense community attention as traders debate its long-term viability against other meme coins, with many discussing its unique holding overlaps with projects like Updog. While some investors view the current price action as a buying opportunity, others remain skeptical about the asset's underlying value and volatility.

BlackRock, Inc. engages in the provision of investment, advisory, and risk management solutions. Its products include single-asset and multi-asset portfolios. The company was founded by Laurence Douglas Fink and Robert Steven Kapito in 1988 and is headquartered in New York, NY.

Blackrock Inc.

BlackRock is currently facing significant selling pressure as investors react to the firm capping quarterly withdrawals from one of its major private credit funds following record redemption requests. The news has sparked wider community concerns about potential liquidity stress and systemic risk within the private credit market, drawing comparisons to past financial downturns.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck is trending as investors rotate into defensive healthcare names while the stock demonstrates strong momentum, further bolstered by positive clinical data for its lung cancer treatments and ongoing pipeline expansion. The community is actively discussing the company's strategic positioning to mitigate upcoming patent expirations through acquisitions and high-profile collaborations within the oncology space.

Veeva Systems, Inc. engages in the provision of industry cloud solutions for the global life sciences industry. The firm's solutions enable pharmaceutical and other life sciences companies to realize the benefits of modern cloud-based architectures and mobile applications for their most critical business functions, without compromising industry-specific functionality or regulatory compliance. Its customer relationship management solutions enable its customers to increase the productivity and compliance of their sales and marketing functions. The firm's regulated content management and collaboration solutions enable its customers to more efficiently manage regulated, content-centric processes across the enterprise. Its customer master solution enables customers to more effectively manage complex healthcare provider and healthcare organization data. The company was founded by Mark Armenante, Peter P. Gassner, Doug Ostler, Mitch Wallace and Matthew J. Wallach on January 12, 2007 and is headquartered in Pleasanton, CA.

Veeva Systems Inc - Ordinary Shares - Class A

Veeva Systems is experiencing a surge in interest as investors digest strong quarterly earnings that showcased consistent revenue growth and a commitment to AI-driven industry cloud solutions. The community is actively weighing the company's long-term competitive positioning and the impact of its strategic pivot to the Vault platform against ongoing market debates regarding SaaS valuations and enterprise software demand.

Listed Funds Trust - Roundhill Magnificent Seven ETF

Roundhill Magnificent Seven ETF

The Roundhill Magnificent Seven ETF (MAGS) is facing intense scrutiny as a new bearish MACD crossover fuels community concerns about a potential correction. Investors are actively debating the sustainability of massive AI-driven capital expenditures versus slowing mega-cap momentum, while many look for rotation opportunities into defensive sectors or smaller-cap stocks.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin (XCN) is currently trending as community members speculate on the upcoming Goliath mainnet launch and its potential impact on enterprise-grade institutional infrastructure. While some investors express optimism regarding long-term accumulation and staking utility, others remain deeply skeptical, frequently debating the project's transparency and citing a pattern of volatility they describe as pump-and-dump activity.

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

The PEPE community is currently polarized by heated debates over political ideologies, overshadowing typical price action discussions. While some traders continue to focus on accumulation strategies and potential meme-coin cycles, others are increasingly frustrated by the shift in board sentiment away from market-related analysis.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladoc Health is gaining attention as investors react to a strategic expansion into Walmarts ecosystem, positioning the company as a broader digital healthcare infrastructure provider. Community sentiment is mixed, with some traders debating the potential for a short squeeze due to high short interest, while long-term investors emphasize the value of its global data footprint and AI-driven growth initiatives.

TokenOS is the world’s most advanced AI-powered Web3 development platform, designed to turn natural language prompts into fully functional, production-ready blockchain applications. From simple tokens and memecoins to complex DeFi protocols, TokenOS automates the creation, deployment, and auditing of smart contracts and dApps with enterprise-grade reliability. By combining advanced language models with blockchain infrastructure, TokenOS removes the barriers of technical expertise, making Web3 development accessible to everyone. With instant deployment, built-in security best practices, and cross-chain support on the roadmap, TokenOS empowers entrepreneurs, developers, and creators to launch tokenized businesses and decentralized applications in seconds.

TokenOS AI

TokenOS AI is trending as investors focus on its v4 launch and a revenue-sharing model that distributes decentralized GPU network earnings to stakers. The community is heavily focused on the high percentage of supply currently locked in long-term staking, which many view as a bullish catalyst for supply scarcity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Bears are Losing Control Over Si-Bone (SIBN), Here's Why It's a 'Buy' Now

Si-Bone (SIBN) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

Wall Street Analysts Predict a 71.13% Upside in Si-Bone (SIBN): Here's  What You Should Know

The average of price targets set by Wall Street analysts indicates a potential upside of 71.1% in Si-Bone (SIBN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

How Much Upside is Left in Si-Bone (SIBN)? Wall Street Analysts Think 65.27%

The consensus price target hints at a 65.3% upside potential for Si-Bone (SIBN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Why Si-Bone Stock Soared by Almost 20% on Tuesday

Key PointsIt posted rather encouraging first-quarter results...

Si-Bone (SIBN) Reports Q1 Loss, Tops Revenue Estimates

Si-Bone (SIBN) delivered earnings and revenue surprises of +41.18% and +2.46%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

SI-Bone (SIBN) Q1 2026 Earnings Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Globus Medical (GMED) Tops Q1 Earnings and Revenue Estimates

Globus Medical (GMED) delivered earnings and revenue surprises of +22.07% and +4.04%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Avanos Medical (AVNS) Lags Q1 Earnings Estimates

Avanos Medical (AVNS) delivered earnings and revenue surprises of -4.35% and +7.61%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

SiBone (SIBN) Expected to Announce Earnings on Monday

SiBone (NASDAQ:SIBN) will be releasing its Q1 2026 earnings after the market closes on Monday, May 11. (View Earnings Report at...

SiBone (NASDAQ:SIBN) Receives Average Rating of "Moderate Buy" from Analysts

Shares of SiBone (NASDAQ:SIBN - Get Free Report) have been given an average rating of "Moderate Buy" by the seven analysts that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating and six have given a buy rating to the company. The average 12-mont...

SI-BONE, Inc. is a medical device company, which engages in the provision of a proprietary minimally invasive surgical implant system to fuse the sacroiliac joint for treatment of musculoskeletal disorders of the sacropelvic anatomy. It offers a proprietary minimally invasive surgical implant system, called iFuse, used to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. The company was founded by Mark A. Reiley and Jeffrey W. Dunn on March 18, 2008 and is headquartered in Santa Clara, CA.

SI-BONE Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

SIBNSI-BONE Inc

Fundamentals

Latest SIBN News